Related Experiment Video
Updated: Aug 11, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
Published on: February 9, 2011
CE: Pediatric Antibiotic Stewardship
1Amanda Good is a certified pediatric NP and a family medicine nurse at Charles River Community Health, Boston. Rita Olans is an associate professor at the MGH Institute of Health Professions, Boston. Contact author: Amanda Good, amanda.good.lynn@gmail.com . The authors and planners have disclosed no potential conflicts of interest, financial or otherwise. A podcast with the authors is available at www.ajnonline.com .
Insights
Reducing antibiotic duration in children is crucial for combating resistance and preventing adverse effects. Shorter treatment courses for common pediatric infections show promise, but more pediatric-specific research is needed.
Area of Science:
- Pediatrics
- Infectious Diseases
- Antimicrobial Stewardship
Background:
- Antibiotic resistance is a growing concern, with most prescriptions originating in ambulatory settings.
- Pediatric antibiotic prescription rates are highest in young children, and early use is linked to health risks.
- Current antimicrobial stewardship often focuses on prescribing, neglecting antibiotic therapy duration.
Purpose of the Study:
- To highlight the critical, yet underexamined, role of antibiotic therapy duration in pediatric antimicrobial stewardship.
- To advocate for evidence-based reduction in antibiotic treatment courses for common pediatric infections.
Main Methods:
- Review of existing research on antibiotic therapy duration in pediatrics.
- Analysis of limitations in current pediatric antibiotic duration studies, including reliance on adult data and industry influence.
Main Results:
- Many common pediatric infections may be safely and effectively treated with shorter antibiotic courses.
- Reduced antibiotic duration can decrease antibiotic resistance and prevent adverse treatment effects.
Conclusions:
- Current pediatric antibiotic duration recommendations often lack strong scientific evidence.
- Further pediatric-specific research is essential to establish optimal, evidence-based antibiotic treatment durations.
- Overcoming challenges like reliance on adult data and clinician hesitancy is vital for advancing pediatric antimicrobial stewardship.
Abstract:
With the rise of antibiotic resistance, antimicrobial stewardship programs can now be found in the ambulatory setting, where nearly 95% of antibiotic prescriptions originate. Judicious use of antibiotics is of particular importance to the ambulatory pediatric provider, as the annual antibiotic prescription rate is highest among children ages two and younger and inappropriate early-life antibiotic use is associated with elevated childhood risk of several medical conditions. While most ambulatory antibiotic stewardship programs have focused on shaping clinician behaviors to prevent unnecessary antibiotic prescribing, duration of antibiotic therapy has been found to be a critical, yet underexamined, facet of antibiotic use. In the past, duration of antibiotic therapy was largely based on convention and expert opinion, with little scientific evidence supporting many of the recommendations. Research suggests that many common pediatric infections such as acute otitis media, community-acquired pneumonia, streptococcal pharyngitis, and urinary tract infections can be effectively and safely treated with reduced courses of antibiotic therapy. In addition to reducing the incidence of antibiotic resistance, a shorter duration of antibiotic therapy may help prevent many adverse effects associated with antibiotic treatment. Current studies on the duration of antibiotic therapy, especially in pediatrics, are limited as they often rely on data extrapolated from adult studies that fail to consider the effects of age-related growth and development on both pharmacokinetics and pharmacodynamics. Future investigation into this topic is also limited by researchers' reliance on subsidies from pharmaceutical companies; clinicians' fear of undertreating infection; and hesitancy to deviate from current standards of care, even when such standards are not evidence based. Despite these challenges, the dangers of inappropriate antibiotic use in the pediatric population warrant further evaluation.
More Related Videos
11:17Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
Related Concept Videos
Antibiotic Selection
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Excretion